vs
化石集团（FOSL）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
化石集团的季度营收约是Ultragenyx Pharmaceutical Inc.的1.3倍（$270.2M vs $207.3M），化石集团净利率更高（-14.8% vs -62.0%，领先47.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -21.1%），化石集团自由现金流更多（$-22.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -11.4%）
化石集团是1984年成立的美国时尚设计制造企业，总部位于得克萨斯州理查森。集团旗下拥有Fossil、Relic、Michele Watch、Skagen、Zodiac Watches等多个品牌，同时也为宝马、彪马、阿玛尼、迈克高仕、DKNY等多个知名品牌代工生产授权配饰。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FOSL vs RARE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.2M | $207.3M |
| 净利润 | $-40.0M | $-128.6M |
| 毛利率 | 49.0% | — |
| 营业利润率 | -8.0% | -54.7% |
| 净利率 | -14.8% | -62.0% |
| 营收同比 | -21.1% | 25.9% |
| 净利润同比 | -257.8% | 3.5% |
| 每股收益（稀释后） | $-0.76 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $270.2M | $207.3M | ||
| Q3 25 | $220.4M | $159.9M | ||
| Q2 25 | $233.3M | $166.5M | ||
| Q1 25 | — | $139.3M | ||
| Q4 24 | $342.3M | $164.6M | ||
| Q3 24 | $287.8M | $139.5M | ||
| Q2 24 | $260.0M | $147.0M | ||
| Q1 24 | $254.9M | $108.8M |
| Q4 25 | $-40.0M | $-128.6M | ||
| Q3 25 | $-2.1M | $-180.4M | ||
| Q2 25 | $-17.9M | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | $-11.2M | $-133.2M | ||
| Q3 24 | $-31.9M | $-133.5M | ||
| Q2 24 | $-38.8M | $-131.6M | ||
| Q1 24 | $-24.3M | $-170.7M |
| Q4 25 | 49.0% | — | ||
| Q3 25 | 57.5% | — | ||
| Q2 25 | 61.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 52.6% | — | ||
| Q1 24 | 52.4% | — |
| Q4 25 | -8.0% | -54.7% | ||
| Q3 25 | 3.9% | -106.9% | ||
| Q2 25 | -2.9% | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | -4.8% | -74.3% | ||
| Q3 24 | -8.5% | -94.6% | ||
| Q2 24 | -13.1% | -79.1% | ||
| Q1 24 | -11.5% | -151.9% |
| Q4 25 | -14.8% | -62.0% | ||
| Q3 25 | -1.0% | -112.8% | ||
| Q2 25 | -7.7% | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | -3.3% | -80.9% | ||
| Q3 24 | -11.1% | -95.7% | ||
| Q2 24 | -14.9% | -89.5% | ||
| Q1 24 | -9.5% | -156.8% |
| Q4 25 | $-0.76 | $-1.28 | ||
| Q3 25 | $-0.04 | $-1.81 | ||
| Q2 25 | $-0.33 | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | $-0.15 | $-1.34 | ||
| Q3 24 | $-0.60 | $-1.40 | ||
| Q2 24 | $-0.73 | $-1.52 | ||
| Q1 24 | $-0.46 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.2M | $421.0M |
| 总债务越低越好 | $169.1M | — |
| 股东权益账面价值 | $112.6M | $-80.0M |
| 总资产 | $701.0M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.50× | — |
8季度趋势，按日历期对齐
| Q4 25 | $79.2M | $421.0M | ||
| Q3 25 | $109.9M | $202.5M | ||
| Q2 25 | $78.3M | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | $123.6M | $174.0M | ||
| Q3 24 | $106.3M | $150.6M | ||
| Q2 24 | $104.9M | $480.7M | ||
| Q1 24 | $112.9M | $112.3M |
| Q4 25 | $169.1M | — | ||
| Q3 25 | $165.6M | — | ||
| Q2 25 | $167.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $162.7M | — | ||
| Q3 24 | $173.4M | — | ||
| Q2 24 | $156.5M | — | ||
| Q1 24 | $202.9M | — |
| Q4 25 | $112.6M | $-80.0M | ||
| Q3 25 | $150.3M | $9.2M | ||
| Q2 25 | $140.6M | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | $148.7M | $255.0M | ||
| Q3 24 | $164.4M | $346.8M | ||
| Q2 24 | $189.6M | $432.4M | ||
| Q1 24 | $229.1M | $140.3M |
| Q4 25 | $701.0M | $1.5B | ||
| Q3 25 | $704.5M | $1.2B | ||
| Q2 25 | $686.0M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $763.6M | $1.5B | ||
| Q3 24 | $812.4M | $1.5B | ||
| Q2 24 | $785.7M | $1.6B | ||
| Q1 24 | $891.0M | $1.3B |
| Q4 25 | 1.50× | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 1.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.09× | — | ||
| Q3 24 | 1.06× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.89× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-22.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | -8.3% | -48.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-46.0M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-22.2M | $-99.8M | ||
| Q3 25 | $9.4M | $-91.4M | ||
| Q2 25 | $-60.4M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | $30.5M | $-79.3M | ||
| Q3 24 | $-22.8M | $-67.0M | ||
| Q2 24 | $38.4M | $-77.0M | ||
| Q1 24 | $622.0K | $-190.7M |
| Q4 25 | $-22.5M | $-100.8M | ||
| Q3 25 | $8.6M | $-92.7M | ||
| Q2 25 | $-60.6M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $28.5M | $-79.5M | ||
| Q3 24 | $-24.1M | $-68.6M | ||
| Q2 24 | $36.6M | $-79.0M | ||
| Q1 24 | $-1.1M | $-193.9M |
| Q4 25 | -8.3% | -48.6% | ||
| Q3 25 | 3.9% | -58.0% | ||
| Q2 25 | -26.0% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | 8.3% | -48.3% | ||
| Q3 24 | -8.4% | -49.2% | ||
| Q2 24 | 14.1% | -53.7% | ||
| Q1 24 | -0.4% | -178.2% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.1% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 0.6% | 0.1% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.7% | 1.4% | ||
| Q1 24 | 0.7% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOSL
| Transferred At Point In Time | $109.7M | 41% |
| Traditional Watches | $91.3M | 34% |
| Other | $50.8M | 19% |
| Leathers | $9.5M | 4% |
| Jewelry | $4.0M | 1% |
| Smartwatches | $3.3M | 1% |
| Products Other | $1.6M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
